
The European Respiratory Society (ERS) 2024 Conference is a premier event in the field of respiratory medicine, gathering leading experts, clinicians, researchers, and healthcare professionals from around the world. Scheduled to take place in Vienna, Austria, the conference will feature a diverse range of sessions, including keynote lectures, symposia, and interactive workshops.
Attendees will explore the latest advancements in respiratory science, treatment strategies, and patient care, with a focus on innovative approaches to managing respiratory diseases. The ERS 2024 Conference promises to be an essential platform for networking, knowledge exchange, and advancing the field of respiratory medicine.
The DelveInsight team will have an excellent chance to broaden their professional network by connecting with industry experts from around the world. They can participate in insightful seminars, respiratory workshops, and educational sessions tailored to the needs and interests of pulmonologists and researchers.
Additionally, DelveInsight will recognize numerous scientific abstracts presented at the ERS conference, showcasing the latest advancements and discoveries from clinical trials in pulmonary, critical care, and sleep medicine. These abstracts highlight pioneering research on new therapies that could potentially revolutionize patient treatment.
Schedule a one-on-one meeting with our expert at ERS 2024 simply by filling up the form towards the right. We look forward to seeing you in Austria!
DelveInsight’s Conference Coverage Services delivers a comprehensive examination of conference outcomes from a range of prominent events, such as ATS, ERS, EULAR, ELCC, and IPF Summit 2023. This in-depth analysis equips businesses with the insights they need for effective competitive intelligence and forecasting market trends, aiding in the development of future strategies.
Our pipeline assessment ensures a holistic perspective of IPF treatment options, clinical trials, and significant aspects of the IPF therapeutics domain, all presented in a report format for accessibility. Our pipeline assessment report type, which includes IPF-focused reports readily available in our Report Store, delivers insights on treatment approaches, mechanisms of action (MoAs), drug components, active pharmaceutical ingredients (APIs), and launch strategies for therapies in late-stage development, enhancing awareness of their launch schedules and strategic initiatives.
Our dedicated research and development analyst is well-versed in the intricacies of the respiratory domain, allowing them to provide valuable insights and guidance to clients seeking to excel in respiratory R&D. They employ a systematic evaluation process, similar to industry standards, for monitoring the progress of each respiratory medicine in pre-clinical and clinical development, as well as for respiratory drugs. DelveInsight’s informative respiratory reports are designed to eliminate uncertainties and address overlooked areas, supplying organizations with timely, strategic intelligence.
Our comprehensive and reputable consulting services are designed to expedite the development of oncology products, offering support in areas such as gathering insights from congresses, providing extensive conference coverage, tracking competitive intelligence across assets and indications, assessing brand visibility and market penetration, analyzing drug therapy adoption rates, and evaluating the diagnostic landscape. These services aim to address various challenges in the respiratory market.
We distinguish ourselves through the recruitment of a dedicated core team focused on Competitive Intelligence. This team comprises analysts, senior analysts, and managers. Our CI team offers unparalleled opportunities and delivers the most precise intelligence, which we share with our collaborators. Moreover, we excel in data collection, primarily aimed at acquiring top-notch intelligence and providing analysis aligned with our partners' consulting objectives.
We invite you to discuss your business concerns with us so that we can work together to find the best solution to help you move forward in the respiratory treatment space.
ASSOCIATE DIRECTOR, FORECASTING
Cheryl Anne Branches
Ms. Cheryl Anne Branches has managerial experience of more than 10 years in providing strategic decision support to top global pharmaceuticals. She holds exceptional experience in project management and business development, having worked with cross-cultural teams. Her expertise lies in the field of Commercial Analytics and Sales Force Effectiveness. Schedule a meeting with Cheryl and assess how DelveInsight’s Consulting portfolio can drive your company to excellence!
The ERS 2024 conference and exhibition will take place in Vienna, Austria, from 7–11 September 2024. Let’s connect!
-